ST Pharm Rises 2.76% Amid COVID-19 (Remdesivir) Theme Uptrend

On the 17th, the COVID-19 (Remdesivir) theme rose by 7.94% compared to the previous day, showing strong performance, while ST Pharm, a stock attracting attention as a related company, surged by 2.76% compared to the previous day. ST Pharm is known as a specialty company in active pharmaceutical ingredients.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, ST Pharm's quant financial score was 7.32 points, ranking 3rd in the quant financial ranking within the COVID-19 (Remdesivir) related theme. This can be interpreted as ST Pharm having relatively low investment attractiveness from a financial perspective. On the other hand, BC World Pharm ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.